Wissenschaftliche Quellen
Grundlagen zu Cholesterin und Lipoproteinen
Ference BA et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. European Heart Journal. 2017.
Grundy SM et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol.
Mach F et al. 2021 ESC Guidelines on cardiovascular disease prevention. European Heart Journal. 2021.
ApoB und LDL-Partikel
Sniderman AD et al. Apolipoprotein B Particles and Cardiovascular Disease. JAMA Cardiology. 2019.
Ference BA et al. Association of genetic variants related to CETP inhibitors and statins with lipoproteins and cardiovascular risk. JAMA. 2017.
Cromwell WC & Otvos JD. LDL Particle Number and Risk of Future Cardiovascular Disease. Current Atherosclerosis Reports. 2004.
Lipoprotein(a)
Tsimikas S. A Test in Context: Lipoprotein(a). Journal of the American College of Cardiology. 2017.
European Atherosclerosis Society Consensus Panel. Lipoprotein(a): Current Knowledge and Future Perspectives.European Heart Journal. 2022.
Entzündung und Atherosklerose
Libby P. Inflammation in Atherosclerosis. Nature. 2002.
Ross R. Atherosclerosis – An Inflammatory Disease. New England Journal of Medicine. 1999.
Keto und Lipidstoffwechsel
Norwitz NG et al. The Lean Mass Hyper-Responder Phenotype. Current Developments in Nutrition. 2022.
Athinarayanan SJ et al. Long-Term Effects of a Continuous Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes. Frontiers in Endocrinology. 2019.
Volek JS, Phinney SD. The Art and Science of Low Carbohydrate Living. Beyond Obesity LLC, 2011 (Standardwerk zur ketogenen Ernährung).